ICD-10 Coding for Empagliflozin(E10.9T, E11.22, E11.22B)
Comprehensive guide on ICD-10 coding for empagliflozin, including documentation requirements and common pitfalls.
Complete code families applicable to Empagliflozin
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E11.9 | Type 2 diabetes mellitus without complications | Use when managing Type 2 Diabetes Mellitus without specific complications. |
|
| I50.23 | Acute on chronic systolic (congestive) heart failure | Use when empagliflozin is prescribed for heart failure with reduced ejection fraction. |
|
| E11.22 | Type 2 diabetes mellitus with diabetic chronic kidney disease | Use when managing Type 2 Diabetes Mellitus with CKD. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutEmpagliflozin
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Empagliflozin.
Using E11.9 without specifying diabetes type.
Impact
Clinical: May lead to inappropriate treatment plans., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Mitigation
Always specify Type 2 Diabetes Mellitus when coding., Use E11.9 only when no complications are present.
Omitting Z79.84 when empagliflozin is prescribed.
Impact
Reimbursement: May result in denied claims or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient medication use.
Mitigation
Always include Z79.84 with E11.9 when empagliflozin is used.
Medication Coding
Impact
Failure to code long-term medication use.
Mitigation
Implement regular audits of medication coding practices.